Company news

PharmaCielo Ltd. news in 2024

PharmaCielo Ltd.'s news releases, calls and decks from 2024, newest first.

View company

PharmaCielo Reports Q3 2024 Financial Results

December 2, 2024

PharmaCielo Announces Intention to Extend Expiry Date of Warrants

November 5, 2024

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024

October 7, 2024

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

August 16, 2024

CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading

July 17, 2024

PharmaCielo Provides Update on Reinstatement for Trading

July 17, 2024

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024

July 4, 2024

PharmaCielo Announces Issuance of Failure to File Cease Trade Order

May 8, 2024

PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors

April 10, 2024

PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil

March 26, 2024

Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo

March 1, 2024

Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products

January 4, 2024

Decks in 2024